IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q1 2024 vs. Q4 2023
How the institutions holding IO Biotech, Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 29.4M | 27.4M | −2.01M (−6.8%) |
| Value | $55.3M | $47.4M | −$7.84M (−14.2%) |
New holders (3)
Institutions that held IO Biotech, Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 314,600 | $550.5K | 0.00% |
| Marex Group plc | 45,000 | $78.8K | 0.00% |
| XTX Topco Ltd | 15,867 | $27.8K | 0.00% |
Sold out (3)
Institutions that held IO Biotech, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| UBS Group AG | 11,204 | $21.1K |
| Wealth Enhancement Advisory Services, LLC | 10,000 | $18.8K |
| Comerica Bank | 2 | $4 |